Corient Private Wealth’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Buy
57,535
+52,275
+994% +$2.48M ﹤0.01% 1235
2026
Q1
$270K Buy
5,260
+1,419
+37% +$99.3K ﹤0.01% 2376
2025
Q4
$354K Buy
+3,841
New +$368K ﹤0.01% 2059
2024
Q4
Sell
-2,185
Closed -$461K 2431
2024
Q3
$461K Buy
2,185
+39
+2% +$6.78K ﹤0.01% 1786
2024
Q2
$287K Buy
+2,146
New +$406K ﹤0.01% 1935
2023
Q4
Sell
-2,101
Closed -$417K 2298
2023
Q3
$417K Buy
2,101
+267
+15% +$67.3K ﹤0.01% 1584
2023
Q2
$595K Buy
+1,834
New +$524K ﹤0.01% 1372

Other funds holding INSP

Corient Private Wealth's INSP Position: Q2 2026 in Review

Corient Private Wealth increased its Inspire Medical Systems (INSP) stake by 994% in Q2 2026, buying an estimated $2.48M and bringing the position to 57,535 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

Corient Private Wealth first reported a position in INSP in Q2 2023 and has held it in 7 quarters since. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Corient Private Wealth held 57,535 shares of Inspire Medical Systems worth $2.57M as of Q2 2026.
  • Corient Private Wealth bought 52,275 Inspire Medical Systems shares in Q2 2026, an estimated $2.48M.
  • Inspire Medical Systems made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1235 holding.
  • Corient Private Wealth first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 7 quarters since.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.